Group One Trading’s Alpha Tau Medical DRTS Stock Holding History

Group One Trading’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$357K	Buy	+28,400	New	+$258K	﹤0.01%	3809

Other funds holding DRTS

GIA

Gem Investment Advisors Teaneck, New Jersey $163M AUM

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Group One Trading's DRTS Position: Q2 2026 in Review

Group One Trading sold out of Alpha Tau Medical (DRTS) in Q2 2026, closing a stake of 100 shares — an estimated $908 sold.

Group One Trading first reported a position in DRTS in Q1 2026 and held it in 1 quarter. The position peaked at $707 in Q1 2026. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

Group One Trading reported no remaining Alpha Tau Medical position as of Q2 2026 after selling out during the quarter.
Group One Trading sold 100 Alpha Tau Medical shares in Q2 2026, an estimated $908.
Group One Trading first reported a position in Alpha Tau Medical in Q1 2026 and held it in 1 quarter.
Group One Trading's Alpha Tau Medical position peaked at $707 in Q1 2026.
74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.